Dr Abdo Alnabulsi, KTP Associate Vertebrate Antibodies Ltd-University of Aberdeen, attended the KTP Associate Conference in Belfast, UK. Abdo Alnabulsi gave a presentation entitled: The Development of Antibodies and Characterisation of Novel Prognostic Biomarkers in Colorectal Cancer.
The study identified novel biomarker targets (proteins) for colorectal cancer prognosis. Monoclonal antibodies were developed to Cell-death-inducing DNA fragment factor 45-like effector A (CIDEA), elongation of very long fatty acids 5 (ELOVL 5) and uncoupling protein 1 (UCP1)
Click here for more details.